The global Lice Treatment Market Size is expected to reach USD 0.46 Billion by 2033. The global Lice Treatment industry size accounted for USD 0.11 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 7.51% from 2023 to 2033. Lice treatment refers to the methods and products used to eliminate lice infestations in humans. Lice are tiny parasitic insects that infest the scalp, hair, and other body parts, feeding on human blood and causing itching, irritation, and discomfort. Lice infestations are common, especially among children, and can spread easily through close personal contact or sharing of contaminated items such as combs, brushes, or bedding. Lice treatment typically involves the use of specific products or techniques that are designed to kill or remove lice and their eggs (nits) from the hair and scalp.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a negative impact on the lice treatment market. The reduced demand for lice treatment products and services due to lockdowns, social distancing measures, and school closures, along with changes in consumer spending priorities, disruptions in supply chains, diversion of healthcare resources, and changes in consumer behavior and hygiene practices, have contributed to the negative impact on the lice treatment market during the pandemic. However, the extent and duration of this impact may vary depending on regional or local outbreaks, government regulations, and overall economic conditions.
Lice Treatment Market Dynamics
The major factors that have impacted the growth of Lice Treatment are as follows:
Drivers:
Innovation in lice treatment products
Advancements in lice treatment technologies, such as new active ingredients, improved formulations, and delivery methods, can drive the market. Novel products that offer convenience, effectiveness and ease of use may be favored by consumers and healthcare providers.
Increased awareness and education
Public awareness campaigns, educational programs, and information dissemination about lice, their transmission, and treatment options can drive demand for lice treatment products. As people become more knowledgeable about lice and the importance of early treatment, they are more likely to seek lice treatment products or services.
Restraint:
- Adverse effects and safety concerns
Some lice treatment products may have potential adverse effects or safety concerns, particularly if not used as directed or if used inappropriately. These concerns may include skin irritation, allergic reactions, or other side effects that can limit the use or demand for certain lice treatment products, especially in sensitive populations such as young children, pregnant women, or individuals with pre-existing health conditions.
Opportunity:
Increasing awareness and education
There is a significant opportunity to increase public awareness and education about lice infestations, their transmission, and the importance of early detection and proper treatment. Improved education and awareness campaigns targeting parents, schools, and healthcare providers can help create a greater demand for lice treatment products and services, driving the market growth.
Lice Treatment Segment Overview
By Type
Based on the Type, the market is segmented based on Pediculosis Capitis, Pediculosis Corporis, and Pediculosis Pubis. During the projection period, the Pediculosis Capitis segment is expected to hold the largest market share. Pediculosis capitis, which refers to head lice infestations, is expected to hold the largest market share in the lice treatment market. Head lice infestations are a common occurrence, particularly among children, and require effective treatment to eliminate the lice and nits (lice eggs). Head lice can cause discomfort, itchiness, and irritation, and are a significant concern for parents, schools, and healthcare providers.
By Treatment
Based on Treatment, the market has been divided into OTC Products and Prescription Medications. The OTC Products segment is expected to hold the largest market share. OTC products offer convenience and accessibility to consumers, allowing them to easily purchase and use these products at home without the need for a prescription or healthcare provider’s intervention. OTC lice treatment products are often cost-effective compared to prescription medications or professional lice treatment services, making them a preferred option for many consumers.
By Distribution Channel
Based on Distribution Channel, the market has been divided into Online platforms, Hospitals, and Clinics. The Online Platform segment is expected to hold the largest market share. Which includes online retailers, e-commerce platforms, and digital marketplaces, and has been growing rapidly in many industries, including healthcare and personal care products. Online platforms offer convenience, accessibility, and a wide range of options to consumers, allowing them to easily purchase lice treatment products online from the comfort of their homes.
Global Lice Treatment Market Share, by Segmentation
Global Lice Treatment Market Regional Analysis
Based on region, the global MHealth market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to dominate the use of the market followed by the Asia-Pacific and Europe regions.
North America Market
North America has been a significant market for lice treatment products and services. The region has historically shown a strong demand for lice treatment due to factors such as high awareness about lice infestations, high prevalence of head lice infestations, and developed healthcare infrastructure. North America is home to a large population, including a significant number of children who are more susceptible to head lice infestations. As a result, there is a continuous demand for effective lice treatment products and services in the region. Additionally, the region has a high level of awareness among parents, schools, and healthcare providers about the importance of timely and effective lice treatment, leading to greater adoption of lice treatment options.
Asia-Pacific Market
The Asia-Pacific region is projected to be a prominent growth market for the lice treatment market. The increasing awareness about lice infestations, changing lifestyles, growing population, and increasing disposable incomes in countries such as China, India, Japan, and South Korea are expected to drive the demand for lice treatment products and services in the Asia-Pacific region. One of the key factors contributing to the growth of the lice treatment market in Asia-Pacific is the high prevalence of head lice infestations in some countries. Factors such as crowded living conditions, lack of awareness about lice prevention and treatment, and changing social behaviors can contribute to the spread of lice infestations in the region, thereby driving the demand for lice treatment products and services.
Competitive Landscape
The market comprises tier-1, tier-2, and local players. With their wide product portfolios, tier-1 and tier-2 players have a global reach. Since their strategic innovations and broad regional presence, companies such as GlaxoSmithKline, Johnson and Johnson Services Inc, Parapro Pharmaceuticals, Fleming Medical Ltd, and Sanofi lead the global Lice Treatment business. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as growth, product releases, and alliances.
Prominent Players:
- Oystershell Consumer Health (Bayer)
- Alliance Pharmaceuticals Ltd
- Perrigo Company plc (Omega Pharma)
- Arbor Pharmaceuticals Inc. (Azurity Pharmaceuticals)
- Prestige Consumer Healthcare Inc.
- GlaxoSmithKline
- Johnson and Johnson Services, Inc.
- Parapro Pharmaceuticals
- Fleming Medical Ltd
- Sanofi
Key Development:
October 2022: Alliance Pharmaceuticals, in partnership with South Florida Family Health and Research Centers, has launched a clinical trial on clinicaltrials.gov to assess the safety and efficacy of Vamousse Spray ‘n’ Go in the treatment of head lice to a 1% Permethrin control shampoo.
Scope of the Report
Global Lice Treatment Market, by Type
- Pediculosis Capitis
- Pediculosis Corporis
- Pediculosis Pubis
Global Lice Treatment Market, by Treatment
- OTC Products
- Prescription Medications
Global Lice Treatment Market, by Distribution Channel
- Online Platform
- Hospitals
- Clinics
Global Lice Treatment Market, by Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Benelux
- Nordic
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Indonesia
- Austalia
- Malaysia
- India
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of Middle East & Africa
| Parameters | Indicators |
|---|---|
| Market Size | 2033: $0.46 Billion |
| CAGR | 7.51% CAGR (2023-2033) |
| Base year | 2022 |
| Forecast Period | 2023-2033 |
| Historical Data | 2021 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Key Segmentations | Type, Treatment, Distribution Channel |
| Geographies Covered | North America, Europe, Asia-Pacific, Latin America, Middle East, Africa |
| Key Vendors | Oystershell Consumer Health (Bayer), Alliance Pharmaceuticals Ltd, Perrigo Company plc (Omega Pharma), Arbor Pharmaceuticals Inc. (Azurity Pharmaceuticals), Prestige Consumer Healthcare Inc, GlaxoSmithKline, Johnson and Johnson Services Inc, Parapro Pharmaceuticals, Fleming Medical Ltd, Sanofi |
| Key Market Opportunities | Increasing awareness and education |
| Key Market Drivers | Innovation in lice treatment products Increased awareness and education |
REPORT CONTENT BRIEF:
- High-level analysis of the current and future Lice Treatment market trends and opportunities
- Detailed analysis of current market drivers, restraining factors, and opportunities in the future
- Lice Treatment market historical market size for the year 2021, and forecast from 2023 to 2033
- Lice Treatment market share analysis at each product level
- Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
- Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
- To identify and understand the various factors involved in the global Lice Treatment market affected by the pandemic
- To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.
Press Release
Travel Insurance Market Soars: 20.14% CAGR
Smart Oilfield Market: 5.14% CAGR Expected
Catalog Management Systems Market Grows: 9.47% CAGR
Secondary Ticket Market Grows: 9.68% CAGR
Private Health Insurance Market: 5.12% CAGR Expected
Digital Content Market Surges: 12.63% CAGR
Crunchy Chocolates Market: 5.10% CAGR Expected
Consumer Finance Market Grows: 8.01% CAGR
Lactic Acid Market Soars: 18.25% CAGR
Neo and Challenger Bank Market Booms: 41.25% CAGR
Frequently Asked Questions (FAQ)
What is the growth rate of the global Lice Treatment market?
The global Lice Treatment market is growing at a CAGR of ~ 30% over the next 10 years
Which region has the highest growth rate in the market of Lice Treatment?
Asia Pacific is expected to register the highest CAGR during 2023-2033
Which region has the largest share of the global Lice Treatment market?
North America holds the largest share in 2022
Who are the key players in the global Lice Treatment market?
Oystershell Consumer Health (Bayer), Alliance Pharmaceuticals Ltd, Perrigo Company plc (Omega Pharma), Arbor Pharmaceuticals Inc. (Azurity Pharmaceuticals), Prestige Consumer Healthcare Inc, GlaxoSmithKline, Johnson and Johnson Services Inc, Parapro Pharmaceuticals, Fleming Medical Ltd, Sanofi are the major companies operating in the market.
Do you offer Post Sale Support?
Yes, we offer 16 hours of analyst support to solve the queries
Do you sell particular sections of a report?
Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.
